HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.

Abstract
We reviewed the clinical course in 43 patients from eight medical centers who were given the diagnosis of chronic mucocutaneous candidiasis, a rare disorder of unknown cause that may occur in childhood. Recurrent or severe infections with organisms other than Candida were seen in 80% of the patients. There were nine cases of septicemia. Seven patients have died; six of these deaths were directly related to non-Candida infectious complications. Endocrine dysfunction, including Addison disease (11 patients) and hypothyroidism (9 patients), was seen in 19 of 43 patients. Immunologic studies failed to reveal a consistent abnormality, although two of five patients with reversed T4/T8 ratios are among those who have died. Ketoconazole was effective in controlling symptoms of candidiasis in most patients. The findings from this study indicate that non-Candida infections cause serious morbidity and may result in death in patients with chronic mucocutaneous candidiasis.
AuthorsH G Herrod
JournalThe Journal of pediatrics (J Pediatr) Vol. 116 Issue 3 Pg. 377-82 (Mar 1990) ISSN: 0022-3476 [Print] United States
PMID2308026 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin A
  • Immunoglobulin G
  • Amphotericin B
  • Flucytosine
  • Ketoconazole
Topics
  • Adolescent
  • Amphotericin B (therapeutic use)
  • Autoimmune Diseases (epidemiology)
  • Candidiasis (complications)
  • Candidiasis, Chronic Mucocutaneous (complications, drug therapy, immunology)
  • Child
  • Child, Preschool
  • Endocrine System Diseases (complications)
  • Family
  • Female
  • Flucytosine (therapeutic use)
  • Humans
  • Immunoglobulin A (metabolism)
  • Immunoglobulin G (metabolism)
  • Incidence
  • Infant
  • Infections (complications, epidemiology, mortality)
  • Ketoconazole (adverse effects, therapeutic use)
  • Lung Diseases (complications)
  • Male
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: